Home › Non-Muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer clinical trials recruiting in the U.S.

33 studies for Non-Muscle Invasive Bladder Cancer are recruiting participants at sites across the United States.

Cities with the most studies

• Dallas, TX10 studies
• Columbus, OH10 studies
• New York City, NY10 studies
• Myrtle Beach, SC9 studies
• Edison, NJ9 studies
• Syracuse, NY8 studies
• Nashville, TN8 studies
• Baltimore, MD8 studies
• Birmingham, AL7 studies
• Philadelphia, PA7 studies
• Atlanta, GA7 studies
• Indianapolis, IN7 studies
• Houston, TX7 studies
• Austin, TX6 studies
• Los Angeles, CA6 studies
• Little Rock, AR6 studies
• Boston, MA6 studies
• San Antonio, TX6 studies
• Chicago, IL6 studies
• St. Louis, MO6 studies
• Durham, NC5 studies
• Bakersfield, CA5 studies
• Cicero, IL5 studies
• Memphis, TN5 studies
• Tampa, FL5 studies
• Kansas City, KS4 studies
• Washington, DC4 studies
• Lakewood, CO4 studies
• Jacksonville, FL4 studies
• Seattle, WA4 studies
• Staten Island, NY4 studies
• Queens, NY4 studies
• Greenburgh, NY4 studies
• East Norwalk, CT4 studies
• Pittsburgh, PA4 studies
• Cincinnati, OH3 studies
• Buffalo, NY3 studies
• Rochester, MN3 studies
• Lafayette, LA3 studies
• New Rochelle, NY3 studies

By state

• Alabama7 studies
• Arizona9 studies
• Arkansas6 studies
• California15 studies
• Colorado5 studies
• District of Columbia4 studies
• Florida15 studies
• Georgia7 studies
• Illinois11 studies
• Indiana8 studies
• Iowa3 studies
• Kansas4 studies
• Louisiana5 studies
• Maryland8 studies
• Massachusetts10 studies
• Michigan7 studies
• Minnesota4 studies
• Missouri7 studies
• New Jersey9 studies
• New York16 studies
• North Carolina6 studies
• Ohio13 studies
• Oregon3 studies
• Pennsylvania9 studies
• South Carolina12 studies
• Tennessee10 studies
• Texas15 studies
• Virginia6 studies
• Washington5 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.